Investigation Overview
November 9, 2016 (Shareholders Foundation) - An investigation on behalf of investors in shares of United Therapeutics Corporation (NASDAQ:UTHR) was announced over potential breaches of fiduciary duties by certain officers and directors at United Therapeutics. The investigation by a law firm concerns whether certain United Therapeutics officers and directors breached their fiduciary d...
You must register (for free) or login to view the entire investigation.